Symptoms of Fatigue and Cognitive/Executive Dysfunction in Major Depressive Disorder before and after Antidepressant Treatment

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 14, 2003, Pages 30-34

  Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; FLUOXETINE; MODAFINIL; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ANOMIA; ASTHENIA; ATTENTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; DRUG EFFICACY; EXECUTIVE DYSFUNCTION; FATIGUE; HUMAN; LEARNING DISORDER; MAJOR DEPRESSION; MEMORY DISORDER; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REVIEW; SEDATION; SHORT TERM MEMORY; SIDE EFFECT; SOMNOLENCE; SPATIAL MEMORY; SYMPTOM; TREATMENT OUTCOME; VERBAL BEHAVIOR; VERBAL MEMORY; WORKING MEMORY;

COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; FATIGUE; HUMANS; TREATMENT OUTCOME;

EID: 0345538676     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Fava M, Uebelacker LA, Alpert JE, et al. Major depressive subtypes and treatment response. Biol Psychiatry 1997;42:568-576
3. Fava GA, Grandi S, Canestrari R, et al. Prodromal symptoms in primary major depressive disorder. J Affect Disord 1990;19:149-152
4. Addington AM, Gallo JJ, Ford DE, et al. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1984. Psychol Med 2001;31:1037-1044
5. Kahn AA, Gardner CO, Prescott CA, et al. Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry 2002;159:1427-1429
6. Worthington J, Fava M, Davidson K, et al. Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacol Bull 1995;31:223-226
7. Judge R, Plewes JM, Kumar V, et al. Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials. J Clin Psychopharmacol 2000;20:666-672
8. Beasley CM Jr, Dornseif BE, Pultz JA, et al. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 1991;52:294-299
9. Fava M, Hoog SL, Judge RA, et al. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. J Clin Psychopharmacol 2002;22:137-147
10. Marraccini RL, Reynolds CF, Houck PR, et al. A double-blind, placebo-controlled assessment of nortriptyline's side effects during 3-year maintenance treatment in elderly patients with recurrent major depression. Int J Geriatr Psychiatry 1999;14:1014-1018
11. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-225
12. Fava M. Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry 2001;62(suppl 18):4-11
13. Masand PS, Anand VS, Tanquary JF. Psychostimulant augmentation of second generation antidepressants: a case series. Depress Anxiety 1998;7:89-91
14. Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000;61:378-381
15. DeBattista C, Solvason HB, Kendrick E, et al. Modafinil as adjunctive in treatment of fatigue and hypersomnia in major depression. In: New Research Abstracts of the American Psychiatric Association 2001 Annual Meeting; New Orleans, La. NR532:144
16. Kogeorgos J, Kotrotsou M, Polonifis N, et al. Modafinil as augmentation of antidepressant therapy. Eur Neuropsychopharmacol 2002;12:S211-S212
17. Schwartz TL, Leso L, Beale M, et al. Modafinil in the treatment of depression with severe comorbid medical illness. Psychosomatics 2002;43:336-337
18. Doghramji K, Menza MA, Rosenthal MH, et al. Adjunct modafinil for fatigue and wakefulness in MDD. In: Syllabus and Proceedings Summary of the American Psychiatric Association 2002 Annual Meeting; Philadelphia, Pa. NR18:9
19. Rush AJ, Weissenburger J, Vinson DB, et al. Neuropsychological dysfunctions in unipolar nonpsychotic major depressions. J Affect Disord 1983;5:281-287
20. Roy-Byrne PP, Weingartner H, Bierer LM, et al. Effortful and automatic cognitive processes in depression. Arch Gen Psychiatry 1986;43:265-267
21. Tancer ME, Brown TM, Evans DL, et al. Impaired effortful cognition in depression. Psychiatry Res 1990;31:161-168
22. Backman L, Forsell Y. Episodic memory functioning in a community-based sample of old adults with major depression: utilization of cognitive support. J Abnorm Psychol 1994;103:361-370
23. Richards PM, Ruff RM. Motivational effects on neuropsychological functioning: comparison of depressed versus nondepressed individuals. J Consult Clin Psychol 1989;57:396-402
24. Isley JE, Moffoot AP, O'Carroll RE. An analysis of memory dysfunction in major depression. J Affect Disord 1995;35:1-9
25. Pelosi L, Slade T, Blumhardt LD, et al. Working memory dysfunction in major depression: an event-related potential study. Clin Neurophysiol 2000;111:1531-43
26. Purcell R, Maruff P, Kyrios M, et al. Neuropsychological function in young patients with unipolar major depression. Psychol Med 1997;27:1277-1285
27. Veiel HO. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 1997;19:587-603
28. Georgieff N, Dominey PF, Michel F, et al. Anomia in major depressive state. Psychiatry Res 1998;77:197-208
29. Miller LS, Faustman WO, Moses JA Jr, et al. Evaluating cognitive impairment in depression with the Luria-Nebraska Neuropsychological Battery: severity correlates and comparisons with nonpsychiatric controls. Psychiatry Res 1991;37:219-227
30. Grant MM, Thase ME, Sweeney JA. Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment. Biol Psychiatry 2001;50:35-43
31. Landro NI, Stiles TC, Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:233-240
32. Bomstein RA, Baker GB, Douglass AB. Depression and memory in major depressive disorder. J Neuropsychiatry Clin Neurosci 1991;3:78-80
33. Van Londen L, Goekoop JG, Zwinderman AH, et al. Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression. Psychol Med 1998;28:275-284
34. Basso MR, Bornstein RA. Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. Neuropsychology 1999;13:557-563
35. Belanoff JK, Kalehzan M, Sund B, et al. Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 2001;158:1612-1616
36. Tarbuck AF, Paykel ES. Effects of major depression on the cognitive function of younger and older subjects. Psychol Med 1995;25:285-295
37. Keegan D, Bowen RC, Blackshaw S, et al. A comparison of fluoxetine and amitriptyline in the treatment of major depression. Int Clin Psychopharmacol 1991;6:117-124
38. Levkovitz Y, Caftofi R, Avital A, et al. The SSRI drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res Bull 2002;58:345-350
39. Meyers BS, Mattis S, Gabriele M, et al. Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives. Psychopharmacol Bull 1991;27:295-299
40. Bangs ME, Petti TA, Janus MD. Fluoxetine-induced memory impairment in an adolescent. J Am Acad Child Adolesc Psychiatry 1994;33:1303-1306
41. Schmitt JA, Kruizinga MJ, Riedel WJ. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J Psychopharmacol 2001;15:173-179
42. Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med 2000;32:210-221
43. Reischies FM, Neu P. Comorbidity of mild cognitive disorder and depression: a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci 2000;250:186-193
44. Jameison K, Dinan TG. Glucocorticoids and cognitive function: from physiology to pathophysiology. Hum Psychopharmacol 2001;16:293-302
45. Sheline YI, Sanghavi M, Mintun MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent depression. J Neurosci 1999;19:5034-5043
46. MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 2003;100:1387-1392